French Biotech Stock Soars On Regulatory Updates

By: Tomas Ronolski - AllPennyStocks.com News

Wednesday, October 23, 2024

A French biotech company is stealing Wednesday’s spotlight after the company announced regulatory updates for the Viaskin Peanut patch in the United States and Europe.

Traders quickly snatched up shares of DBV Technologies S.A. (Nasdaq:DBVT) following the announcement, pushing shares of this micro cap up to $1.05/share (+50.00%) at the early session high. This move marks a strong breakout for this stock as it has finally climbed out of a multi-month downtrend.

DBV Technologies SA is a biotechnology company that provides therapy for food and pediatric allergy patients. The company focuses on discovering, developing, manufacturing, and commercializing treatments for severe allergies in the United States and other global markets. Its method of delivering biologically active compounds to the immune system is through self-administered and non-invasive products. It also explores potential applications of its platform in vaccines and other immune diseases.

Copyright © 2024 AllPennyStocks.com. All rights reserved. Republication or redistribution of AllPennyStocks.com's content is expressly prohibited without the prior written consent of AllPennyStocks.com. AllPennyStocks.com shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Other Penny Stock Movers

Battery Company Moving Higher Following LOI for Joint Venture

French Biotech Stock Soars On Regulatory Updates

Acquisition Of 80-Megawatt Bitcoin Mining Facility Causes Massive Buying Pressure

Biotech Shares Rip Following Collaboration Announcement For Monkeypox Research

Battery Company Moving Higher Following LOI for Joint Venture

Junior Miner Trading Higher on Reorganization Plans

High grocery and rental costs plaguing Canadians, new survey finds

Minimum wage of some temporary foreign workers set to change

AllPennyStocks.com Favorites

Next-Generation Obesity Treatments Aim to Solve Muscle Loss Problem

Enable Free Access to Unlock Up to Two Articles Per Month.

Equities Rally on Earnings Beats

Enable Free Access to Unlock Up to Two Articles Per Month.

Nasdaq listed, Akebia Therapeutics Inc. looks ready to rally as the stock exhibited a Golden Cross (50 DMA / 200 DMA). With a closing price of $1.64, we continue to monitor this technical signal for future potential upward movement.

TSX-Venture traded, Copper Road Resources Inc. took off in Tuesday's trading session. Shares climbed an impressive 200.00%, ending the day at $0.05.

Trading on the Nasdaq, Ensysce Biosciences Inc. rallied 161.65%, closing at $0.54 on Tuesday.

Biotech Breakthrough: Promising Therapies Target Pulmonary Fibrosis

Enable Free Access to Unlock Up to Two Articles Per Month.

Cutting-Edge Brain Therapy Signals Big Upside for Investors

Enable Free Access to Unlock Up to Two Articles Per Month.

WANT TO UNLOCK ACCESS TO:

●Stock Picks

●Penny Stocks to Watch

●Market Commentary

●Watch Lists

And much more by becoming an AllPennyStocks.com Free Member.

Free Membership Has Its Perks!

By entering your email address, you agree to AllPennyStocks.com’s disclaimer and privacy policy.

Register via:

You understand that AllPennyStocks.com and its affiliates may use your address to send updates, ads and offers.

Go Back

Email Registration

By clicking on the "Start Viewing AllPennyStocks.com Pro Articles" button below, you are confirming that you understand and accept that the content we are showing you is not meant to be used as financial advice. This content is merely for educational purposes and shows our readers real-time examples of trading strategies based on technical and fundamental analysis principles, along with stock market commentary.

Investing in stocks is risky stuff, trust us on that one, and past performance may not be indicative of future performance.

We want everyone to enjoy this information for its educational value, and we remind everyone that we are not liable for losses or damages of any kind from trading based on our information. The only thing we will recommend is to consult with a financial advisor prior to making any trades.

With that said, if we're on the same page here and you agree to our disclaimer, click the button below and enjoy all of our AllPennyStocks.com Pro content.

© Copyright 2024 AllPennyStocks.com Media Inc. All rights reserved. Nasdaq Stocks: Information delayed 15 minutes. Non-Nasdaq Stocks: Information delayed 20 minutes.
Bid and Ask quotation information for NYSE and AMEX securities is only available on a real time basis. Data is provided by QuoteMedia.com.

French Biotech Stock Soars On Regulatory Updates

Other Penny Stock Movers

Battery Company Moving Higher Following LOI for Joint Venture

French Biotech Stock Soars On Regulatory Updates

Acquisition Of 80-Megawatt Bitcoin Mining Facility Causes Massive Buying Pressure

Most Popular

AllPennyStocks.com Favorites